Page last updated: 2024-08-23

phenyl acetate and Pulmonary Disease, Chronic Obstructive

phenyl acetate has been researched along with Pulmonary Disease, Chronic Obstructive in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (46.15)29.6817
2010's5 (38.46)24.3611
2020's2 (15.38)2.80

Authors

AuthorsStudies
Heo, SH; Jang, Y; Jung, SY; Kim, J; Kim, NH; Kim, OH; Kim, SJ; Lee, SH; Lee, SW; Lim, SE; Shon, CH; Yoo, HJ; Yun, S1
Gallo, O; Mangia, PP; Pradelli, L; Ritrovato, D1
Foster, M; Snell, N; Vestbo, J1
Binková, I; Doubková, M; Foret, F; Greguš, M; Kindlová, D; Kubáň, P; Merta, Z; Plutinský, M; Pokojová, E; Skřičková, J1
Abdel Kawy, HS1
Jauhiainen, A; Taib, Z1
Canfield, J; Chu, JW; Faul, JL; Kuschner, WG; Wilson, SR1
Drakatos, P; Karkoulias, K; Lykouras, D; Sampsonas, F; Spiropoulos, K1
Anderson, R; Feldman, C; Theron, AJ; Tintinger, GR1
Kolm, G; Riedelberger, K; Schmid, R; Van den Hoven, R; Zappe, H1
Böhme, S; Jörres, RA; Kanniess, F; Magnussen, H; Nielsen-Gode, D; Richter, K; Zühlke, IE1
Kumar, B; Rubinstein, I; Schriever, C1
Celik, P; Havlucu, Y; Sakar, A; Turkdogan, P; Yorgancioglu, A; Yuksel, H1

Reviews

2 review(s) available for phenyl acetate and Pulmonary Disease, Chronic Obstructive

ArticleYear
Targeting leukotrienes for the treatment of COPD?
    Inflammation & allergy drug targets, 2009, Volume: 8, Issue:4

    Topics: 5-Lipoxygenase-Activating Proteins; Acetates; Arachidonate 5-Lipoxygenase; Bronchoconstriction; Capillary Permeability; Carrier Proteins; CD8-Positive T-Lymphocytes; Cell Movement; Chromones; Cyclopropanes; Eosinophils; Humans; Indoles; Leukotriene Antagonists; Leukotrienes; Membrane Proteins; Neutrophils; Phenylcarbamates; Pulmonary Disease, Chronic Obstructive; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds

2009
Montelukast: more than a cysteinyl leukotriene receptor antagonist?
    TheScientificWorldJournal, 2010, Dec-14, Volume: 10

    Topics: Acetates; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Cyclopropanes; Humans; Leukotriene Antagonists; Neutrophils; Pulmonary Disease, Chronic Obstructive; Quinolines; Receptors, Leukotriene; Sulfides

2010

Trials

4 trial(s) available for phenyl acetate and Pulmonary Disease, Chronic Obstructive

ArticleYear
Efficacy and safety of AZD1981, a CRTH2 receptor antagonist, in patients with moderate to severe COPD.
    Respiratory medicine, 2013, Volume: 107, Issue:11

    Topics: Acetates; Adult; Aged; Aged, 80 and over; Bronchodilator Agents; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Indoles; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Receptors, Immunologic; Receptors, Prostaglandin; Severity of Illness Index; Treatment Outcome; Vital Capacity

2013
The effect of an inhaled corticosteroid on glucose control in type 2 diabetes.
    Clinical medicine & research, 2009, Volume: 7, Issue:1-2

    Topics: Acetates; Administration, Inhalation; Adrenal Cortex Hormones; Aged; Androstadienes; Anti-Asthmatic Agents; Bronchodilator Agents; Cross-Over Studies; Cyclopropanes; Diabetes Complications; Diabetes Mellitus, Type 2; Double-Blind Method; Fluticasone; Glucose; Glycated Hemoglobin; Humans; Male; Middle Aged; Placebos; Pulmonary Disease, Chronic Obstructive; Quinolines; Sulfides; Treatment Outcome

2009
Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD.
    The European respiratory journal, 2003, Volume: 22, Issue:6

    Topics: Acetates; Administration, Inhalation; Administration, Oral; Aged; Airway Obstruction; Albuterol; Bronchodilator Agents; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Female; Humans; Leukotriene Antagonists; Male; Metered Dose Inhalers; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quinolines; Recovery of Function; Respiratory Function Tests; Saline Solution, Hypertonic; Solutions; Sulfides; Treatment Outcome

2003
Short-term effects of montelukast in stable patients with moderate to severe COPD.
    Respiratory medicine, 2005, Volume: 99, Issue:4

    Topics: Acetates; Aged; Cyclopropanes; Dyspnea; Female; Humans; Leukotriene Antagonists; Male; Middle Aged; Neutrophils; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolines; Respiratory Function Tests; Single-Blind Method; Sputum; Sulfides

2005

Other Studies

7 other study(ies) available for phenyl acetate and Pulmonary Disease, Chronic Obstructive

ArticleYear
Gut microbiota composition and metabolite profiling in smokers: a comparative study between emphysema and asymptomatic individuals with therapeutic implications.
    Thorax, 2023, Volume: 78, Issue:11

    Topics: Acetates; Animals; Disease Models, Animal; Emphysema; Forced Expiratory Volume; Gastrointestinal Microbiome; Humans; Mice; Propionates; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Smokers

2023
Cost-Utility Analysis of Fixed-Dose Combination of Indacaterol Acetate Glycopyrronium Bromide and Mometasone Furoate as a Maintenance Treatment in Adult Patients with Asthma Not Adequately Controlled with a Maintenance Combination of a Long-Acting Beta-Ag
    Clinical drug investigation, 2021, Volume: 41, Issue:9

    Topics: Acetates; Adrenal Cortex Hormones; Adult; Asthma; Bronchodilator Agents; Cost-Benefit Analysis; Drug Combinations; Glycopyrrolate; Humans; Indans; Mometasone Furoate; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolones; Treatment Outcome

2021
Monitoring the ionic content of exhaled breath condensate in various respiratory diseases by capillary electrophoresis with contactless conductivity detection.
    Journal of breath research, 2015, May-06, Volume: 9, Issue:2

    Topics: Acetates; Adult; Aged; Ammonium Compounds; Asthma; Breath Tests; Butyrates; Calcium; Chlorides; Crown Ethers; Cystic Fibrosis; Electrophoresis, Capillary; Female; Humans; Hydrogen-Ion Concentration; Ions; Lactic Acid; Magnesium; Male; Middle Aged; Nitrates; Nitrites; Potassium; Propionates; Pulmonary Disease, Chronic Obstructive; Pulmonary Fibrosis; Sarcoidosis, Pulmonary; Sodium; Sulfates

2015
Montelukast versus Dexamethasone Treatment in a Guinea Pig Model of Chronic Pulmonary Neutrophilic Inflammation.
    COPD, 2016, Volume: 13, Issue:4

    Topics: Acetates; Animals; Bronchoalveolar Lavage Fluid; Chronic Disease; Cyclopropanes; Dexamethasone; Disease Models, Animal; Glucocorticoids; Guinea Pigs; Histone Deacetylases; Inflammation; Leukocyte Count; Leukotriene Antagonists; Leukotriene B4; Lipopolysaccharides; Lung; Male; Malondialdehyde; Neutrophils; Pulmonary Disease, Chronic Obstructive; Quinolines; Respiratory Hypersensitivity; Sulfides; Tumor Necrosis Factor-alpha

2016
COPD biomarkers as tools for decision making in early clinical drug development.
    Biomarkers in medicine, 2016, Volume: 10, Issue:5

    Topics: Acetates; Biomarkers; Clinical Trials as Topic; Cluster Analysis; Endpoint Determination; Humans; Interleukin-6; Lung; Prognosis; Pulmonary Disease, Chronic Obstructive; Pyrazines

2016
Efficacy of montelukast in the treatment of chronic obstructive pulmonary disease in five horses.
    The Veterinary record, 2003, Jun-28, Volume: 152, Issue:26

    Topics: Acetates; Animals; Cyclopropanes; Female; Horse Diseases; Horses; Leukotriene Antagonists; Male; Pulmonary Disease, Chronic Obstructive; Quinolines; Respiration; Severity of Illness Index; Sulfides; Treatment Outcome

2003
Long-term montelukast therapy in moderate to severe COPD--a preliminary observation.
    Respiratory medicine, 2004, Volume: 98, Issue:2

    Topics: Acetates; Aged; Cyclopropanes; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Long-Term Care; Male; Pulmonary Disease, Chronic Obstructive; Quinolines; Retrospective Studies; Sulfides; Vital Capacity

2004